MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
about
Recent progress in the study of methylated tumor suppressor genes in gastric cancerDNA methylation gene-based models indicating independent poor outcome in prostate cancer.Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.Genomic and genetic alterations influence the progression of gastric cancer.Expression of myelin and lymphocyte protein (MAL) in oral carcinogenesis.CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancerClinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.Suppression of MAL gene expression is associated with colorectal cancer metastasis.CpG island hypermethylation in gastric carcinoma and its premalignant lesions.Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer.Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.Decreased MALL expression negatively impacts colorectal cancer patient survivalGenome-wide analysis identifies colonic genes differentially associated with serum leptin and insulin concentrations in C57BL/6J mice fed a high-fat diet.Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer.MAL and TMEM220 are novel DNA methylation markers in human gastric cancer.Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer.Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer PatientsUpregulation of myelin and lymphocyte protein (MAL) after traumatic spinal cord injury in rats.A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.Genome-Wide Analysis of Barrett's Adenocarcinoma. A First Step Towards Identifying Patients at Risk and Developing Therapeutic Paths.Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae.Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.
P2860
Q27009359-5921CCAB-068B-4479-B06E-50C77128EFE2Q34174356-ACF7FE20-BAB9-493C-9DB2-6C87EBDC2178Q34410542-C7C0F4E8-D2DE-48BC-8257-45361915B64FQ34497423-7597591C-DC0E-462C-B111-483511BA9E56Q34504539-A81F1EF8-A010-4BE9-B636-71D447B3DFA3Q35051708-FC3AC8F3-E41B-4B1C-8CD0-6ACE4FF6D3B9Q35677409-9E4BE3D6-24B6-46C2-B59E-6F5A1A82236EQ35871200-E661D0B1-9738-4248-BC34-2EBF5CD3FBB9Q36343388-E0FAAF13-D64E-4AD5-88A0-DC1DCC3A6B4DQ36753304-5592F217-719B-416E-9213-4E5FEDC40C0AQ36836937-39D9E197-A3F1-43E9-BE1A-2B67E10CB2A4Q37225710-4EC585AF-5147-4805-B508-E9C65BAB1420Q37629433-691CE668-59A8-4C58-99AE-AAEC8EF18776Q37824622-CE377C22-1C2C-45EB-B913-DFD9B480021DQ38097524-F6AE819B-57D1-42C8-9281-6813D34F1D2AQ38762957-3017FD8B-B90B-452A-AFC8-0A4C39A2783EQ39603266-E28E194D-4D7D-4412-8F5F-8E3202905C16Q40316397-98F7E3A2-0A5A-448F-930F-73010A02067AQ42517147-A4C7E02A-3C9F-4EE0-B952-CEFAE434C550Q45774420-44445E17-4E7E-4F50-B2FB-6E24E9C530ACQ47338470-B5502191-70D9-4E42-BA2E-39AF46A9B45DQ51542785-72E4AABF-4F1F-4776-9F92-9CBA138D35E2Q53291854-D8BF9F1A-8BD9-4475-B675-BFB04A4CDBACQ54381660-7F4FE8D3-1B25-4AF5-8495-241ED25CE5F3
P2860
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
@en
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.
@nl
type
label
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
@en
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.
@nl
prefLabel
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
@en
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.
@nl
P2093
P2860
P356
P1476
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
@en
P2093
B Carvalho
C J H van de Velde
G A Meijer
H I Grabsch
N C T van Grieken
P J F Snijders
R M Overmeer
T E Buffart
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604777
P407
P577
2008-11-11T00:00:00Z